Alendronat Viatris 70 mg נורווגיה - נורבגית - Statens legemiddelverk

alendronat viatris 70 mg

viatris limited - alendronatnatriumtrihydrat - tablett - 70 mg

Optinate Septimum 35 mg נורווגיה - נורבגית - Statens legemiddelverk

optinate septimum 35 mg

theramex ireland limited - risedronatnatrium - tablett, filmdrasjert - 35 mg

Pamidronatdinatrium Pfizer 9 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

pamidronatdinatrium pfizer 9 mg/ ml

pfizer as - dinatriumpamidronat - konsentrat til infusjonsvæske - 9 mg/ ml

Pamidronatdinatrium Pfizer 3 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

pamidronatdinatrium pfizer 3 mg/ ml

pfizer as - dinatriumpamidronat - konsentrat til infusjonsvæske, oppløsning - 3 mg/ ml

Pamidronatdinatrium Pfizer 6 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

pamidronatdinatrium pfizer 6 mg/ ml

pfizer as - dinatriumpamidronat - konsentrat til infusjonsvæske - 6 mg/ ml

Risedronat Amneal 35 mg נורווגיה - נורבגית - Statens legemiddelverk

risedronat amneal 35 mg

amneal pharma europe limited - natriumrisedronat-2½-hydrat - tablett, filmdrasjert - 35 mg

Zoledronsyre Fresenius Kabi 4 mg/5 ml נורווגיה - נורבגית - Statens legemiddelverk

zoledronsyre fresenius kabi 4 mg/5 ml

fresenius kabi norge as - halden - zoledronsyremonohydrat - konsentrat til infusjonsvæske, oppløsning - 4 mg/5 ml

Valproat Life Medical 100 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

valproat life medical 100 mg/ ml

life medical aps (1) - natriumvalproat - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml

Piqray האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

piqray

novartis europharm limited  - alpelisib - bryst neoplasms - antineoplastiske midler - piqray er indisert i kombinasjon med fulvestrant for behandling av postmenopausale kvinner, og menn, med hormon-reseptor (hr)-positiv, human epidermal vekstfaktor reseptor 2 (her2)-negative, lokalt avansert eller metastatisk brystkreft med en pik3ca mutasjon etter progresjon av sykdommen etter endokrin terapi som monoterapi (se punkt 5..

Libmeldy האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - andre nervesystemet narkotika - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.